A method for estimating the probability of adverse drug reactions

C. A. Naranjo, U. Busto, Edward M. Sellers, +6

Clinical Pharmacology & Therapeutics

DiagnosisPharmacotherapyLogistic AnalysisAdverse Drug ReactionDrug Resistance +26

Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.

D. Wu, S V Otton, U. Busto, +2

British Journal of Clinical Pharmacology

PharmacotherapyCyp2d6 ActivityExperimental PharmacologyMolecular PharmacologyMedicinal Chemistry +16

Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.

U. Busto, C. A. Naranjo

British Journal of Clinical Pharmacology

Sex-related variations in the frequency and characteristics of adverse drug reactions.

C Domecq, Naranjo Ca, I Ruíz, +1

PubMed

PharmacotherapySocial SciencesAdverse Drug ReactionDrug HypersensitivityRisk Fators +17

Diazepam tapering in detoxification for high-dose benzodiazepine abuse

M Harrison, U. Busto, C. A. Naranjo, +2

Clinical Pharmacology & Therapeutics

Substance AbuseDaily TaperingMedian Benzodiazepine DosePsychoactive DrugPsychiatry +12

Clinical aspects of chronic use of alprazolam and lorazepam

Myroslava K. Romach, U. Busto, Gail Somer, +2

American Journal of Psychiatry

Benzodiazepine use and abuse in Canada.

U. Busto, Krista L. Lanctôt, Pearl Isaac, +1

PubMed

Substance UseDrug PolicyPharmacotherapyHarm ReductionAdverse Drug Reaction +14

Benzodiazepine-associated emergencies in Toronto

U. Busto, Howard L. Kaplan, Edward M. Sellers

American Journal of Psychiatry

Opioid EpidemicSubstance UsePsychotropic MedicationPharmacotherapyAdverse Drug Reaction +16

Comparative Study on Benzodiazepine Use in Canada and Chile

Inés Ruiz, J. Offermanns, Krista L. Lanctôt, +1

The Journal of Clinical Pharmacology

Drug SafetySubstance AbuseHypnotic BenzodiazepinesPsychiatryAddiction +13

Use of prescription and nonprescription hypnotics in a Canadian elderly population.

U. Busto, Beth Sproule, Kathryn Knight, +1

PubMed